JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 1991; 17:957-962
© 1991 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Munkvad, S
Right arrow Articles by Kluft, C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Munkvad, S
Right arrow Articles by Kluft, C

Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: a randomized placebo-controlled study

S Munkvad, J Jespersen, J Gram, and C Kluft

Department of Clinical Chemistry, Ribe County Hospital, Esbjerg, Denmark.

In a randomized placebo-controlled study, seven patients with acute myocardial infarction allocated to intravenous treatment with 100 mg of recombinant tissue-type plasminogen activator (rt-PA) and seven patients allocated to placebo were studied during eight sampling periods before and after treatment. Seven patients with acute myocardial infarction treated intravenously with 1.5 million U of streptokinase were later studied during two sampling periods before and after treatment. The placebo group showed no significant deviations of endogenous factor XII-dependent fibrinolytic activity (p greater than 0.05). In the rt-PA group, this activity decreased significantly (p less than 0.001) after the infusion and remained depressed throughout the 1st 4 days. A significant decrease in activity (p less than 0.05) was also found in the streptokinase-treated patients. The depletion of factor XII-dependent fibrinolytic activity was not due to generation of inhibition or a depletion of factor XII, prekallikrein and plasminogen, but could be related to the proactivator of this system. It is concluded that rt-PA (and streptokinase) treatment in patients with acute myocardial infarction causes a prolonged depletion of factor XII-dependent fibrinolytic activity. This depression of endogenous fibrinolytic activity needs to be evaluated in relation to the enhanced risk of coronary reocclusion after thrombolytic therapy.


This article has been cited by other articles:


Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
R. W. Colman, J. V. White, S. Scovell, A. Stadnicki, and R. B. Sartor
Kininogens Are Antithrombotic Proteins In Vivo
Arterioscler. Thromb. Vasc. Biol., September 1, 1999; 19(9): 2245 - 2250.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G. Motta, R. Rojkjaer, A. A.K. Hasan, D. B. Cines, and A. H. Schmaier
High Molecular Weight Kininogen Regulates Prekallikrein Assembly and Activation on Endothelial Cells: A Novel Mechanism for Contact Activation
Blood, January 15, 1998; 91(2): 516 - 528.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. W. Colman and A. H. Schmaier
Contact System: A Vascular Biology Modulator With Anticoagulant, Profibrinolytic, Antiadhesive, and Proinflammatory Attributes
Blood, November 15, 1997; 90(10): 3819 - 3843.
[Full Text] [PDF]

Home page
 CirculationHome page
H. M. Hoffmeister, M. Jur, H. P. Wendel, W. Heller, and L. Seipel
Alterations of Coagulation and Fibrinolytic and Kallikrein-Kinin Systems in the Acute and Postacute Phases in Patients With Unstable Angina Pectoris
Circulation, May 15, 1995; 91(10): 2520 - 2527.
[Abstract] [Full Text]


HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1991 by the American College of Cardiology Foundation.